In 2025, the landscape of cancer treatment is witnessing a promising shift with the repurposing of well-known drugs. One such drug, Ivermectin, traditionally used as an antiparasitic agent, is now being tested in Ivermectin cancer trials U.S. 2025 for its potential anti-tumor effects. This article delves into the latest research findings, NIH-funded studies, and clinical...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek